Preventing latent tuberculosis among HIV-infected patients: efficacious and effective, yet inefficient?
Rieder
Hans L
HL
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D019072:Antibiotic Prophylaxis; D000995:Antitubercular Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D015658:HIV Infections / Q000150:complications*; D015994:Incidence; D007538:Isoniazid / Q000627:therapeutic use*; D013557:Switzerland; D014376:Tuberculosis / Q000517:prevention & control*; D017735:Virus Latency
D000995:Antitubercular Agents; D007538:Isoniazid